Effect of adipose-derived mesenchymal stem cell transplantation on vascular calcification in rats with adenine-induced kidney disease

Scientific Reports
Shinya YokoteTakashi Yokoo

Abstract

Previous studies have investigated the use of mesenchymal stem cells (MSCs) to treat damaged kidneys. However, the effect of adipose-derived MSCs (ASCs) on vascular calcification in chronic kidney disease (CKD) is still poorly understood. In the present study, we explored the potential of ASCs for the treatment of CKD and vascular calcification. CKD was induced in male Sprague-Dawley rats by feeding them a diet containing 0.75% adenine for 4 weeks. ASCs transplantation significantly reduced serum inorganic phosphorus (Pi) as compared to that in the control. The histopathology of the kidneys showed a greater dilation of tubular lumens and interstitial fibrosis in the control group. Calcium and Pi contents of the aorta in the ASCs transplantation group were lower than those in the control group. Von Kossa staining of the thoracic aorta media revealed that ASCs transplantation suppressed vascular calcification. Thus, this study revealed that autogenic ASCs transplantation inhibits kidney damage and suppresses the progression of vascular calcification in the CKD rat model, suggesting that autogenic ASCs transplantation is a novel approach for preventing the progression of CKD and vascular calcification.

References

Feb 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Takashi YokooTatsuo Hosoya
Mar 10, 2006·Journal of the American Society of Nephrology : JASN·Takashi YokooEiji Kobayashi
Apr 28, 2006·Transplantation·Yoji HakamataEiji Kobayashi
Jan 16, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ellen NevenVeerle Persy
Aug 10, 2010·Biochemical and Biophysical Research Communications·Ayinuer AdijiangToshimitsu Niwa
Jun 17, 2011·Clinical Science·Sandra VillanuevaCarlos P Vio
Jun 18, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Rafael KramannRebekka K Schneider
Oct 12, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Shunsuke YamadaTakanari Kitazono
Apr 20, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Shinya YokoteTatsuo Hosoya
Jan 4, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Allan J CollinsLawrence Agodoa
Dec 22, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Marina Morigi, Ariela Benigni
May 25, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Rafael KramannRebekka K Schneider
Oct 9, 2014·Kidney International·Allyson HartBertram L Kasiske
Mar 18, 2015·Lancet·Thaminda LiyanageVlado Perkovic
Sep 4, 2015·American Journal of Physiology. Renal Physiology·Narihito TatsumotoTakanari Kitazono
Sep 24, 2015·Proceedings of the National Academy of Sciences of the United States of America·Shinya YokoteTakashi Yokoo
Oct 13, 2015·Nature Biotechnology·Ryuji MorizaneJoseph V Bonventre
Nov 21, 2015·Journal of the American Society of Nephrology : JASN·Sazia SharminRyuichi Nishinakamura
Feb 24, 2016·Frontiers in Physiology·Consuelo Merino-GonzálezClaudio Aguayo
Sep 30, 2016·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Wenduo GuQingbo Xu

❮ Previous
Next ❯

Methods Mentioned

BETA
urine collection
transgenic
flow cytometry
enzyme-linked immunosorbent assay

Software Mentioned

GraphPad
GraphPad Prism
MetaValue

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.